David A. Siegel Maravai Lifesciences Holdings, Inc. Transaction History

Two Sigma Advisers, LP

$47 Billion
Q3 2025

A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Maravai Lifesciences Holdings, Inc. stock. As of the latest transaction made, Two Sigma Advisers, LP holds 1,651,400 shares of MRVI stock, worth $6.01 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

1,651,400

Previous 2,224,594 25.77%

Holding current value

$6.01 Million

Previous $5.36 Million 11.6%

% of portfolio

0.01%

Previous 0.01%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	SELL	$2.03 - $2.89 $1.16 Million - $1.66 Million	-573,194 Reduced 25.77%	1,651,400 $4.74 Million
Q2 2025 Aug 14, 2025	SELL	$1.72 - $2.47 $23,058 - $33,112	-13,406 Reduced 0.6%	2,224,594 $5.36 Million
Q1 2025 May 15, 2025	BUY	$2.21 - $6.13 $4.47 Million - $12.4 Million	2,021,500 Added 933.72%	2,238,000 $4.95 Million
Q4 2024 Feb 14, 2025	SELL	$4.42 - $8.5 $2 Million - $3.85 Million	-453,000 Reduced 67.66%	216,500 $1.18 Million
Q3 2024 Nov 14, 2024	SELL	$6.84 - $9.73 $1.98 Million - $2.81 Million	-289,300 Reduced 30.17%	669,500 $5.56 Million

Q2 2024 Aug 14, 2024	SELL	$6.87 - $11.34 $2.78 Million - $4.58 Million	-404,000 Reduced 29.64%	958,800 $6.87 Million
Q1 2024 May 15, 2024	SELL	$5.11 - $8.76 $409,311 - $701,676	-80,100 Reduced 5.55%	1,362,800 $11.8 Million
Q4 2023 Feb 14, 2024	SELL	$4.7 - $9.87 $1.37 Million - $2.87 Million	-290,600 Reduced 16.76%	1,442,900 $9.45 Million
Q3 2023 Nov 14, 2023	SELL	$9.14 - $12.85 $6.84 Million - $9.61 Million	-748,100 Reduced 30.15%	1,733,500 $17.3 Million
Q2 2023 Aug 14, 2023	BUY	$12.09 - $15.0 $11.8 Million - $14.6 Million	974,500 Added 64.66%	2,481,600 $30.8 Million
Q1 2023 May 15, 2023	BUY	$12.99 - $16.48 $4.98 Million - $6.32 Million	383,400 Added 34.12%	1,507,100 $21.1 Million
Q4 2022 Feb 14, 2023	BUY	$12.5 - $24.78 $8.32 Million - $16.5 Million	665,400 Added 145.19%	1,123,700 $16.1 Million
Q3 2022 Nov 14, 2022	BUY	$20.6 - $30.37 $3.42 Million - $5.04 Million	165,800 Added 56.68%	458,300 $11.7 Million
Q2 2022 Aug 15, 2022	BUY	$26.05 - $37.48 $4.58 Million - $6.6 Million	176,000 Added 151.07%	292,500 $8.31 Million
Q1 2022 May 16, 2022	BUY	$24.46 - $40.92 $2.11 Million - $3.52 Million	86,100 Added 283.22%	116,500 $4.11 Million
Q4 2021 Feb 14, 2022	BUY	$35.0 - $45.94 $868,000 - $1.14 Million	24,800 Added 442.86%	30,400 $1.27 Million
Q3 2021 Nov 15, 2021	BUY	$36.8 - $60.62 $206,079 - $339,472	5,600 New	5,600 $275,000
Q2 2021 Aug 16, 2021	SELL	$32.46 - $45.0 $1.87 Million - $2.59 Million	-57,600 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$25.8 - $38.49 $15,480 - $23,094	600 Added 1.05%	57,600 $2.05 Million
Q4 2020 Feb 16, 2021	BUY	$24.5 - $30.86 $1.4 Million - $1.76 Million	57,000 New	57,000 $1.6 Million

Others Institutions Holding MRVI

# of Institutions

183

Shares Held

132M

Call Options Held

688K

Put Options Held

11.6K

View Full List

About MARAVAI LIFESCIENCES HOLDINGS, INC.

Ticker MRVI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 131,540,000
Market Cap $479M
Description
Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for dia...

More about MRVI

Track David A. Siegel's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.

Account